These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6397971

  • 1. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

  • 2. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 3. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A, Horváth T, Beró T, Kádas I, Pakodi F, Jávor T.
    Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
    [Abstract] [Full Text] [Related]

  • 5. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ, Borg R.
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract] [Full Text] [Related]

  • 6. (+)-Cyanidanol-3 for alcoholic liver disease: results of a six-month clinical trial.
    World MJ, Aps EJ, Shaw GK, Thomson AD.
    Alcohol Alcohol; 1984; 19(1):23-9. PubMed ID: 6149758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN, Okorokov AN, Fedorov NE, Laktionova AA, Sidorenko LF.
    Ter Arkh; 1986; 58(2):76-9. PubMed ID: 3704946
    [Abstract] [Full Text] [Related]

  • 13. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W, Leube G.
    Med Klin; 1978 Oct 13; 73(41):1432-6. PubMed ID: 703670
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I, Schmidt FW, Müller R, Ranft U, Wildhirt E, Holzer E, Wallnöfer H, Korb G.
    Dtsch Med Wochenschr; 1980 Mar 07; 105(10):330-2. PubMed ID: 6153953
    [Abstract] [Full Text] [Related]

  • 16. Palmitoyl-catechin for alcoholic liver disease: results of a three-month clinical trial.
    World MJ, Ryle PR, Aps EJ, Shaw GK, Thomson AD.
    Alcohol Alcohol; 1987 Mar 07; 22(4):331-40. PubMed ID: 3322310
    [Abstract] [Full Text] [Related]

  • 17. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.
    Depew W, Boyer T, Omata M, Redeker A, Reynolds T.
    Gastroenterology; 1980 Mar 07; 78(3):524-9. PubMed ID: 6985881
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens].
    Mansurov KhKh, Mirodzhov GK, Mishanina ZG, Pavlov VL.
    Ter Arkh; 1985 Mar 07; 57(2):77-80. PubMed ID: 3890253
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A, Tsvetkova V, Krŭstev Z, Kostova N, Lukanov L.
    Vutr Boles; 1985 Mar 07; 24(5):39-43. PubMed ID: 4090451
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.